Your browser doesn't support javascript.
loading
Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.
Purdue, Mark P; Rhee, Jongeun; Moore, Lee; Gao, Xiaohua; Sun, Xuezheng; Kirk, Erin; Bencko, Vladimir; Janout, Vladimir; Mates, Dana; Zaridze, David; Petruzella, Stacey; Hakimi, Abraham Ari; Linehan, William Marston; Chanock, Stephen J; Brennan, Paul; Furberg, Helena; Troester, Melissa; Rothman, Nathaniel.
Afiliação
  • Purdue MP; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Rhee J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Moore L; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Gao X; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Sun X; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Kirk E; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Bencko V; First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
  • Janout V; Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
  • Mates D; Department of Environmental Health, Institute of Public Health, Bucharest, Romania.
  • Zaridze D; Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russia.
  • Petruzella S; Departments of Surgery and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Hakimi AA; Departments of Surgery and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Linehan WM; Department of Health and Human Services, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Chanock SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Brennan P; Section of Genetics, International Agency for Research on Cancer, Lyon, France.
  • Furberg H; Departments of Surgery and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Troester M; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Rothman N; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Int J Cancer ; 149(7): 1448-1454, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34058014
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article